Unitary supplementary certificate for medicinal products
This dossier concerns a unitary supplementary certificate (SPC) for medicinal products. Amendments address the duration and scope of protection relative to the basic patent, avoiding overprotection, biological medicinal products and INNs, the timely entry of generics and biosimilars, a centralised examination procedure by the Office with national patent offices, fees, appeals and the Unified Patent Court, and disclosure of direct financial support for research.
Procedure timeline
- Committee amendments tabled13 Nov 2023
- Plenary vote — Adopted28 Feb 2024 · On the Commission proposal (the draft law)
- In progress — not yet concluded
Plenary votes
1 roll-call votesIn plenary, Parliament usually votes in steps: first on amendments to the text (sometimes split into parts, so Members can accept one half of a sentence and reject the other), then on the text as a whole. The “main vote” is the one that adopts or rejects the text itself. Each vote below shows exactly which step it was. How voting works →
- 28 Feb 2024Main voteAdoptedOn the Commission proposal (the draft law)Official label: Proposition de la Commission · what was voted ↗518 for29 against70 abstentions88 did not voteForAgainstAbst.
Click a group to see each Member’s position.
Vote data: HowTheyVote.eu (ODbL, attribution) / European Parliament · roll-call votes only
How groups usually vote on similar files
Based on 56 past main roll-call votes on JURI-responsible procedures, Jul 2019 → 2026-07-04.
Statistical baseline from past roll-call votes; not a forecast. · roll-call votes only
Follow this procedure — subscribe to its votes (RSS)
Official amendment documents
Connections
See these connections as a navigable graph — and walk from there to anything else.
Explore the graphMembers who amended this procedure
5 Members · by amendment countThe amendments, in full text
336 amendmentsEvery amendment as tabled — original text, proposed change and justification, with a link to the official PDF.